Phase II Study of Irinotecan and Panitumumab
This study is currently recruiting participants.
Verified January 2013 by University of Pittsburgh
Sponsor:
Michael Gibson
Collaborator:
Amgen
Information provided by (Responsible Party):
Michael Gibson, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00836277
First received: February 3, 2009
Last updated: January 22, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |